Status:
COMPLETED
CYFIP1 and PKM2 Synergistically Regulate ROS and Glycolysis in Colorectal Cancer Through the AKT/mTOR/HIF-1α Cascad
Lead Sponsor:
hui hou
Conditions:
Colorectal Cancer (CRC)
Specimens Are to be Collected From Subjects Who Are Having or Have Had a Fluid or Tissue Removed, a Biopsy or a Blood or Bone Marrow Draw
Eligibility:
All Genders
Brief Summary
Collect some tumor tissue specimens from patients who have undergone colorectal cancer surgery and conduct experiments such as immunohistochemistry to observe the expression of related genes in colore...
Detailed Description
We need to collect postoperative specimens and adjacent normal tissue specimens from patients with colorectal cancer for immunohistochemical staining. There is no need to conduct any other grouping of...
Eligibility Criteria
Inclusion
- (1) Patients diagnosed with colorectal cancer who received surgical treatment and postoperative chemotherapy (2) Patients who were conscious of their condition and voluntarily participated (3) No other serious underlying diseases
Exclusion
- (1) Concurrent other serious chronic diseases or organ damage (2) Diagnosed with benign colorectal tumors
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT07197151
Start Date
August 1 2022
End Date
September 1 2025
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China, 230032